866-997-4948(US-Canada Toll Free)

2017-2022 Global and Japan Blood system drugs Market Analysis Report

Published By :

Jp Research

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 127 Pages

The global Blood system drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Blood system drugs market's development status and future trend in the global and Japan. It splits Blood system drugs market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
ACTAVIS ELIZABETH
AKORN
ALLERGAN SALES LLC
AMNEAL PHARMS
APOTEX
ARALEZ PHARMS
ASTRAZENECA PHARMS
AVEDRO INC
BARR
BAXTER HLTHCARE
BIOKEY
BRECKENRIDGE PHARM
BRISTOL MYERS SQUIBB
CHIESI USA INC
CLOVER PHARMS
EMCURE PHARMS LTD
FERRING PHARMS INC
FRESENIUS KABI USA
GENENTECH
GLAND PHARMA LTD
GLENMARK PHARMS LTD
HERITAGE PHARMA
HOSPIRA
INVAGEN PHARMS
IPCA LABS LTD
LUITPOLD
MEDICURE
MYLAN
NEW RIVER
PFIZER

Geographically, this report splits the Global market into the following regions:
Asia Pacific
Japan
Tokyo
Yokohama
Osaka
Nagoya
Others
China
Korea
India
Others
Europe
France
Germany
United Kingdom
Italy
Russia
Others
North America
United States
Canada
Latin America
Brazil
Mexico
Others
Southeast Asia
Singapore
Malaysia
Vietnam
Myanmar
Thailand
Indonesia
Philippines
Others
Middle East & Africa
Saudi Arabia
Iran
UAE
Turkey
Israel
Egypt
South Africa
Others

On the basis of product, the Blood system drugs market is primarily split into
Blood system drugs Market, by Antianemic Agents
Ferrous sulfate
Ferrous succinate
RHUEPO
Iron-dextrin
Vitamin B12
Folic acid
Mecobalamin
Cobamamide
Epogen/Procrit
NeoRecormon
Dynepo
Eporatio/Biopoin
Aranesp/NESP
Mircera/CERA
Binocrit
Abseamed
Epoetin Alfa Hexal
Retacrit/Silapo
Blood system drugs Market, by Antiplatelet drug
Aspirin
Dipyridamole
Clopidogrel
Prasugrel
Ticagrelor
Glycoprotein
Aggrastat
Cilostazol
Ticlopidine
Cangrelor
Vorapaxar
Atopaxar
Sarpogrelate
Blood system drugs Market, by Coagulant Drugs
Thrombin
Etamsylate
Menadione Sodium Bisulfite
Vitamin K1
Aminomethylbenzoic Acid
Desmopressin acetate
Human Coagulation Factor
Prothrombin Complex
Artificial fibrinogen
Aminomethylbenzoic Acid
Tranexamic acid
Aprotinin
Aminocaproic Acid
Carbazochrome
Pituitrin
Blood system drugs Market, by Anticoagulant and thrombolyti
heparin
urokinase
Warfarin
Bishydroxycoumarin
Streptokinase
Silteplase
Blood system drugs Market, by blood volume expander
Hydroxyethyl starch 40
Dextran
Polyglucose

Key Applications
department of hematology
Internal Medicine
department of surgery
Pharmacy
Hospital


Table of Contents



2017-2022 Global and Japan Blood system drugs Market Analysis Report

1 Blood system drugs Overview

1.1 Product Overview and Scope of Blood system drugs

1.2 Global and Japan Blood system drugs Market by Applications/End Users

1.2.1 Japan Blood system drugs Sales () and Market Share Comparison by Applications (2012-2017)

1.2.1.1 Japan Blood system drugs Sales () and Market Share by Applications (2012-2017)

1.2.1.2 Japan Blood system drugs Sales Growth Rate (%) by Applications (2012-2017)

1.2.1.3 Market Drivers and Opportunities

1.2.2 Japan Blood system drugs Sales () and Market Share Comparison by Applications (2012-2017)

1.2.3 Global Blood system drugs Sales by Application (2012-2017)

1.2.3.1 Global Blood system drugs Sales () and Market Share by Applications (2012-2017)

1.2.3.2 Global Blood system drugs Sales Growth Rate (%) by Applications (2012-2017)

1.2.3.3 Market Drivers and Opportunities

1.2.4 Global Blood system drugs Sales () and Market Share Comparison by Applications (2012-2017)

1.2.5 department of hematology

1.2.6 Internal Medicine

1.2.7 department of surgery

1.2.8 Pharmacy

1.2.9 Hospital

1.3 Global and Japan Market Size (Sales and Revenue) of Blood system drugs (2012-2017)

1.3.1 Japan Market Size (Sales and Revenue) of Blood system drugs (2012-2017)

1.3.1.1 Japan Blood system drugs Sales () and Growth Rate (%) (2012-2017)

1.3.1.2 Japan Blood system drugs Revenue (Million USD) and Growth Rate (2012-2017)

1.3.2 Global Market Size (Sales and Revenue) of Blood system drugs (2012-2017)

1.3.2.1 Global Blood system drugs Sales () and Growth Rate (%) (2012-2017)

1.3.2.2 Global Blood system drugs Revenue (Million USD) and Growth Rate (2012-2017)

1.4 Global and Japan Classification of Blood system drugs by Antianemic Agents

1.4.1 Japan Blood system drugs Sales () and Market Share by Antianemic Agents (2012-2017)

1.4.2 Global Blood system drugs Sales () and Market Share by Antianemic Agents (2012-2017)

1.4.3 Japan Blood system drugs Revenue (Million USD) and Market Share by Antianemic Agents (2012-2017)

1.4.4 Global Blood system drugs Revenue (Million USD) and Market Share by Antianemic Agents (2012-2017)

1.4.5 Japan Blood system drugs Price () by Antianemic Agents (2012-2017)

1.4.6 Global Blood system drugs Price () by Antianemic Agents (2012-2017)

1.4.7 Japan Blood system drugs Sales Growth Rate (%) by Antianemic Agents (2012-2017)

1.4.8 Global Blood system drugs Sales Growth Rate (%) by Antianemic Agents (2012-2017)

1.4.9 Ferrous sulfate

1.4.10 Ferrous succinate

1.4.11 RHUEPO

1.4.12 Iron-dextrin

1.4.13 Vitamin B12

1.4.14 Folic acid

1.4.15 Mecobalamin

1.4.16 Cobamamide

1.5 Global and Japan Classification of Blood system drugs by Antiplatelet drug

1.5.1 Japan Blood system drugs Sales () and Market Share by Antiplatelet drug (2012-2017)

1.5.2 Global Blood system drugs Sales () and Market Share by Antiplatelet drug (2012-2017)

1.5.3 Japan Blood system drugs Revenue (Million USD) and Market Share by Antiplatelet drug (2012-2017)

1.5.4 Global Blood system drugs Revenue (Million USD) and Market Share by Antiplatelet drug (2012-2017)

1.5.5 Japan Blood system drugs Price () by Antiplatelet drug (2012-2017)

1.5.6 Global Blood system drugs Price () by Antiplatelet drug (2012-2017)

1.5.7 Japan Blood system drugs Sales Growth Rate (%) by Antiplatelet drug (2012-2017)

1.5.8 Global Blood system drugs Sales Growth Rate (%) by Antiplatelet drug (2012-2017)

1.5.9 Aspirin

1.5.10 Dipyridamole

1.5.11 Clopidogrel

1.5.12 Prasugrel

1.5.13 Ticagrelor

1.5.14 Cangrelor

1.5.15 Vorapaxar

1.5.16 Atopaxar

1.5.17 Sarpogrelate

1.6 Global and Japan Classification of Blood system drugs by Coagulant Drugs

1.6.1 Japan Blood system drugs Sales () and Market Share by Coagulant Drugs (2012-2017)

1.6.2 Global Blood system drugs Sales () and Market Share by Coagulant Drugs (2012-2017)

1.6.3 Japan Blood system drugs Revenue (Million USD) and Market Share by Coagulant Drugs (2012-2017)

1.6.4 Global Blood system drugs Revenue (Million USD) and Market Share by Coagulant Drugs (2012-2017)

1.6.5 Japan Blood system drugs Price () by Coagulant Drugs (2012-2017)

1.6.6 Global Blood system drugs Price () by Coagulant Drugs (2012-2017)

1.6.7 Japan Blood system drugs Sales Growth Rate (%) by Coagulant Drugs (2012-2017)

1.6.8 Global Blood system drugs Sales Growth Rate (%) by Coagulant Drugs (2012-2017)

1.6.9 Thrombin

1.6.10 Etamsylate

1.6.11 Menadione Sodium Bisulfite

1.6.12 Vitamin K1

1.6.13 Aminomethylbenzoic Acid

1.6.14 Desmopressin acetate

1.6.15 Human Coagulation Factor

1.6.16 Prothrombin Complex

1.6.17 Artificial fibrinogen

1.6.18 Aminomethylbenzoic Acid

1.6.19 Tranexamic acid

1.6.20 Aprotinin

1.6.21 Aminocaproic Acid

1.6.22 Carbazochrome

1.6.23 Pituitrin

1.7 Global and Japan Classification of Blood system drugs by Anticoagulant and thrombolytic

1.7.1 Japan Blood system drugs Sales () and Market Share by Anticoagulant and thrombolytic (2012-2017)

1.7.2 Global Blood system drugs Sales () and Market Share by Anticoagulant and thrombolytic (2012-2017)

1.7.3 Japan Blood system drugs Revenue (Million USD) and Market Share by Anticoagulant and thrombolytic (2012-2017)

1.7.4 Global Blood system drugs Revenue (Million USD) and Market Share by Anticoagulant and thrombolytic (2012-2017)

1.7.5 Japan Blood system drugs Price () by Anticoagulant and thrombolytic (2012-2017)

1.7.6 Global Blood system drugs Price () by Anticoagulant and thrombolytic (2012-2017)

1.7.7 Japan Blood system drugs Sales Growth Rate (%) by Anticoagulant and thrombolytic (2012-2017)

1.7.8 Global Blood system drugs Sales Growth Rate (%) by Anticoagulant and thrombolytic (2012-2017)

1.7.9 heparin

1.7.10 urokinase

1.7.11 Warfarin

1.7.12 Bishydroxycoumarin

1.7.13 Streptokinase

1.7.14 Silteplase

1.8 Global and Japan Classification of Blood system drugs by blood volume expander

1.8.1 Japan Blood system drugs Sales () and Market Share by blood volume expander (2012-2017)

1.8.2 Global Blood system drugs Sales () and Market Share by blood volume expander (2012-2017)

1.8.3 Japan Blood system drugs Revenue (Million USD) and Market Share by blood volume expander (2012-2017)

1.8.4 Global Blood system drugs Revenue (Million USD) and Market Share by blood volume expander (2012-2017)

1.8.5 Japan Blood system drugs Price () by blood volume expander (2012-2017)

1.8.6 Global Blood system drugs Price () by blood volume expander (2012-2017)

1.8.7 Japan Blood system drugs Sales Growth Rate (%) by blood volume expander (2012-2017)

1.8.8 Global Blood system drugs Sales Growth Rate (%) by blood volume expander (2012-2017)

1.8.9 Hydroxyethyl starch 40

1.8.10 Dextran

1.8.11 Polyglucose



2 Global and Japan Blood system drugs Market Competition by Players/Manufacturers

2.1 Japan Blood system drugs Market Competition by Players/Manufacturers

2.1.1 Japan Blood system drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.1.2 Japan Blood system drugs Revenue and Share by Players/Manufacturers (2012-2017)

2.1.3 Japan Blood system drugs Average Price () by Players/Manufacturers (2012-2017)

2.1.4 Japan Blood system drugs Market Competitive Situation and Trends

2.1.4.1 Japan Blood system drugs Market Concentration Rate

2.1.4.2 Japan Blood system drugs Market Share of Top 3 and Top 5 Players/Manufacturers

2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market

2.1.5 Japan Players/Manufacturers Blood system drugs Manufacturing Base Distribution, Sales Area, Product Types

2.2 Global Blood system drugs Market Competition by Players/Manufacturers

2.2.1 Global Blood system drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.2.2 Global Blood system drugs Revenue and Share by Players/Manufacturers (2012-2017)

2.2.3 Global Blood system drugs Average Price () by Players/Manufacturers (2012-2017)

2.2.4 Global Blood system drugs Market Competitive Situation and Trends

2.2.4.1 Global Blood system drugs Market Concentration Rate

2.2.4.2 Global Blood system drugs Market Share of Top 3 and Top 5 Players/Manufacturers

2.2.4.3 Mergers & Acquisitions, Expansion in Global Market

2.2.5 Global Players/Manufacturers Blood system drugs Manufacturing Base Distribution, Sales Area, Product Types



3 Global and Japan Blood system drugs Sales and Revenue by Regions (2012-2017)

3.1 Asia Pacific Blood system drugs Sales and Revenue by Regions (2012-2017)

3.1.1 Japan Blood system drugs Sales and Revenue (2012-2017)

3.1.1.1 Japan Blood system drugs Sales () and Market Share (2012-2017)

3.1.1.2 Japan Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.1.3 Japan Blood system drugs Price ()(2012-2017)

3.1.2 China Blood system drugs Sales and Revenue (2012-2017)

3.1.2.1 China Blood system drugs Sales () and Market Share (2012-2017)

3.1.2.2 China Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.2.3 China Blood system drugs Price ()(2012-2017)

3.1.3 Korea Blood system drugs Sales and Revenue (2012-2017)

3.1.3.1 Korea Blood system drugs Sales () and Market Share (2012-2017)

3.1.3.2 Korea Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.3.3 Korea Blood system drugs Price ()(2012-2017)

3.1.4 India Blood system drugs Sales and Revenue (2012-2017)

3.1.4.1 India Blood system drugs Sales () and Market Share (2012-2017)

3.1.4.2 India Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.4.3 India Blood system drugs Price ()(2012-2017)

3.1.5 Others Blood system drugs Sales and Revenue (2012-2017)

3.1.5.1 Others Blood system drugs Sales () and Market Share (2012-2017)

3.1.5.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.5.3 Others Blood system drugs Price ()(2012-2017)

3.2 Europe Blood system drugs Sales and Revenue by Regions (2012-2017)

3.2.1 France Blood system drugs Sales and Revenue (2012-2017)

3.2.1.1 France Blood system drugs Sales () and Market Share (2012-2017)

3.2.1.2 France Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.1.3 France Blood system drugs Price ()(2012-2017)

3.2.2 Germany Blood system drugs Sales and Revenue (2012-2017)

3.2.2.1 Germany Blood system drugs Sales () and Market Share (2012-2017)

3.2.2.2 Germany Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.2.3 Germany Blood system drugs Price ()(2012-2017)

3.2.3 United Kingdom Blood system drugs Sales and Revenue (2012-2017)

3.2.3.1 United Kingdom Blood system drugs Sales () and Market Share (2012-2017)

3.2.3.2 United Kingdom Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.3.3 United Kingdom Blood system drugs Price ()(2012-2017)

3.2.4 Italy Blood system drugs Sales and Revenue (2012-2017)

3.2.4.1 Italy Blood system drugs Sales () and Market Share (2012-2017)

3.2.4.2 Italy Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.4.3 Italy Blood system drugs Price ()(2012-2017)

3.2.5 Russia Blood system drugs Sales and Revenue (2012-2017)

3.2.5.1 Russia Blood system drugs Sales () and Market Share (2012-2017)

3.2.5.2 Russia Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.5.3 Russia Blood system drugs Price ()(2012-2017)

3.2.6 Others Blood system drugs Sales and Revenue (2012-2017)

3.2.6.1 Others Blood system drugs Sales () and Market Share (2012-2017)

3.2.6.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.6.3 Others Blood system drugs Price ()(2012-2017)

3.3 North America Blood system drugs Sales and Revenue by Regions (2012-2017)

3.3.1 United States Blood system drugs Sales and Revenue (2012-2017)

3.3.1.1 United States Blood system drugs Sales () and Market Share (2012-2017)

3.3.1.2 United States Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.3.1.3 United States Blood system drugs Price ()(2012-2017)

3.3.2 Canada Blood system drugs Sales and Revenue (2012-2017)

3.3.2.1 Canada Blood system drugs Sales () and Market Share (2012-2017)

3.3.2.2 Canada Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.3.2.3 Canada Blood system drugs Price ()(2012-2017)

3.4 Latin America Blood system drugs Sales and Revenue by Regions (2012-2017)

3.4.1 Brazil Blood system drugs Sales and Revenue (2012-2017)

3.4.1.1 Brazil Blood system drugs Sales () and Market Share (2012-2017)

3.4.1.2 Brazil Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.4.1.3 Brazil Blood system drugs Price ()(2012-2017)

3.4.2 Mexico Blood system drugs Sales and Revenue (2012-2017)

3.4.2.1 Mexico Blood system drugs Sales () and Market Share (2012-2017)

3.4.2.2 Mexico Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.4.2.3 Mexico Blood system drugs Price ()(2012-2017)

3.4.3 Others Blood system drugs Sales and Revenue (2012-2017)

3.4.3.1 Others Blood system drugs Sales () and Market Share (2012-2017)

3.4.3.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.4.3.3 Others Blood system drugs Price ()(2012-2017)

3.5 Southeast Asia Blood system drugs Sales and Revenue by Regions (2012-2017)

3.5.1 Singapore Blood system drugs Sales and Revenue (2012-2017)

3.5.1.1 Singapore Blood system drugs Sales () and Market Share (2012-2017)

3.5.1.2 Singapore Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.1.3 Singapore Blood system drugs Price ()(2012-2017)

3.5.2 Malaysia Blood system drugs Sales and Revenue (2012-2017)

3.5.2.1 Malaysia Blood system drugs Sales () and Market Share (2012-2017)

3.5.2.2 Malaysia Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.2.3 Malaysia Blood system drugs Price ()(2012-2017)

3.5.3 Vietnam Blood system drugs Sales and Revenue (2012-2017)

3.5.3.1 Vietnam Blood system drugs Sales () and Market Share (2012-2017)

3.5.3.2 Vietnam Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.3.3 Vietnam Blood system drugs Price ()(2012-2017)

3.5.4 Myanmar Blood system drugs Sales and Revenue (2012-2017)

3.5.4.1 Myanmar Blood system drugs Sales () and Market Share (2012-2017)

3.5.4.2 Myanmar Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.4.3 Myanmar Blood system drugs Price ()(2012-2017)

3.5.5 Thailand Blood system drugs Sales and Revenue (2012-2017)

3.5.5.1 Thailand Blood system drugs Sales () and Market Share (2012-2017)

3.5.5.2 Thailand Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.5.3 Thailand Blood system drugs Price ()(2012-2017)

3.5.6 Indonesia Blood system drugs Sales and Revenue (2012-2017)

3.5.6.1 Indonesia Blood system drugs Sales () and Market Share (2012-2017)

3.5.6.2 Indonesia Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.6.3 Indonesia Blood system drugs Price ()(2012-2017)

3.5.7 Philippines Blood system drugs Sales and Revenue (2012-2017)

3.5.7.1 Philippines Blood system drugs Sales () and Market Share (2012-2017)

3.5.7.2 Philippines Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.7.3 Philippines Blood system drugs Price ()(2012-2017)

3.5.8 Others Blood system drugs Sales and Revenue (2012-2017)

3.5.8.1 Others Blood system drugs Sales () and Market Share (2012-2017)

3.5.8.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.8.3 Others Blood system drugs Price ()(2012-2017)

3.6 Middle East & Africa Blood system drugs Sales and Revenue by Regions (2012-2017)

3.6.1 Saudi Arabia Blood system drugs Sales and Revenue (2012-2017)

3.6.1.1 Saudi Arabia Blood system drugs Sales () and Market Share (2012-2017)

3.6.1.2 Saudi Arabia Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.1.3 Saudi Arabia Blood system drugs Price ()(2012-2017)

3.6.2 Iran Blood system drugs Sales and Revenue (2012-2017)

3.6.2.1 Iran Blood system drugs Sales () and Market Share (2012-2017)

3.6.2.2 Iran Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.2.3 Iran Blood system drugs Price ()(2012-2017)

3.6.3 UAE Blood system drugs Sales and Revenue (2012-2017)

3.6.3.1 UAE Blood system drugs Sales () and Market Share (2012-2017)

3.6.3.2 UAE Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.3.3 UAE Blood system drugs Price ()(2012-2017)

3.6.4 Turkey Blood system drugs Sales and Revenue (2012-2017)

3.6.4.1 Turkey Blood system drugs Sales () and Market Share (2012-2017)

3.6.4.2 Turkey Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.4.3 Turkey Blood system drugs Price ()(2012-2017)

3.6.5 Israel Blood system drugs Sales and Revenue (2012-2017)

3.6.5.1 Israel Blood system drugs Sales () and Market Share (2012-2017)

3.6.5.2 Israel Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.5.3 Israel Blood system drugs Price ()(2012-2017)

3.6.6 Egypt Blood system drugs Sales and Revenue (2012-2017)

3.6.6.1 Egypt Blood system drugs Sales () and Market Share (2012-2017)

3.6.6.2 Egypt Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.6.3 Egypt Blood system drugs Price ()(2012-2017)

3.6.7 South Africa Blood system drugs Sales and Revenue (2012-2017)

3.6.7.1 South Africa Blood system drugs Sales () and Market Share (2012-2017)

3.6.7.2 South Africa Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.7.3 South Africa Blood system drugs Price ()(2012-2017)

3.6.8 Others Blood system drugs Sales and Revenue (2012-2017)

3.6.8.1 Others Blood system drugs Sales () and Market Share (2012-2017)

3.6.8.2 Others Blood system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.8.3 Others Blood system drugs Price ()(2012-2017)



4 Global and Japan Blood system drugs Players/Manufacturers Profiles and Sales Data

4.1 ACTAVIS ELIZABETH

4.1.1 Company Basic Information, Manufacturing Base and Competitors

4.1.2 Blood system drugs Product Category, Application and Specification

4.1.2.1 Product A

4.1.2.2 Product B

4.1.3 ACTAVIS ELIZABETH Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.1.4 Main Business/Business Overview

4.2 AKORN

4.2.1 Company Basic Information, Manufacturing Base and Competitors

4.2.2 Blood system drugs Product Category, Application and Specification

4.2.2.1 Product A

4.2.2.2 Product B

4.2.3 AKORN Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.2.4 Main Business/Business Overview

4.3 ALLERGAN SALES LLC

4.3.1 Company Basic Information, Manufacturing Base and Competitors

4.3.2 Blood system drugs Product Category, Application and Specification

4.3.2.1 Product A

4.3.2.2 Product B

4.3.3 ALLERGAN SALES LLC Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.3.4 Main Business/Business Overview

4.4 AMNEAL PHARMS

4.4.1 Company Basic Information, Manufacturing Base and Competitors

4.4.2 Blood system drugs Product Category, Application and Specification

4.4.2.1 Product A

4.4.2.2 Product B

4.4.3 AMNEAL PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.4.4 Main Business/Business Overview

4.5 APOTEX

4.5.1 Company Basic Information, Manufacturing Base and Competitors

4.5.2 Blood system drugs Product Category, Application and Specification

4.5.2.1 Product A

4.5.2.2 Product B

4.5.3 APOTEX Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.5.4 Main Business/Business Overview

4.6 ARALEZ PHARMS

4.6.1 Company Basic Information, Manufacturing Base and Competitors

4.6.2 Blood system drugs Product Category, Application and Specification

4.6.2.1 Product A

4.6.2.2 Product B

4.6.3 ARALEZ PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.6.4 Main Business/Business Overview

4.7 ASTRAZENECA PHARMS

4.7.1 Company Basic Information, Manufacturing Base and Competitors

4.7.2 Blood system drugs Product Category, Application and Specification

4.7.2.1 Product A

4.7.2.2 Product B

4.7.3 ASTRAZENECA PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.7.4 Main Business/Business Overview

4.8 AVEDRO INC

4.8.1 Company Basic Information, Manufacturing Base and Competitors

4.8.2 Blood system drugs Product Category, Application and Specification

4.8.2.1 Product A

4.8.2.2 Product B

4.8.3 AVEDRO INC Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.8.4 Main Business/Business Overview

4.9 BARR

4.9.1 Company Basic Information, Manufacturing Base and Competitors

4.9.2 Blood system drugs Product Category, Application and Specification

4.9.2.1 Product A

4.9.2.2 Product B

4.9.3 BARR Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.9.4 Main Business/Business Overview

4.10 BAXTER HLTHCARE

4.10.1 Company Basic Information, Manufacturing Base and Competitors

4.10.2 Blood system drugs Product Category, Application and Specification

4.10.2.1 Product A

4.10.2.2 Product B

4.10.3 BAXTER HLTHCARE Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.10.4 Main Business/Business Overview

4.11 BIOKEY

4.12 BRECKENRIDGE PHARM

4.13 BRISTOL MYERS SQUIBB

4.14 CHIESI USA INC

4.15 CLOVER PHARMS

4.16 EMCURE PHARMS LTD

4.17 FERRING PHARMS INC

4.18 FRESENIUS KABI USA

4.19 GENENTECH

4.20 GLAND PHARMA LTD

4.21 GLENMARK PHARMS LTD

4.22 HERITAGE PHARMA

4.23 HOSPIRA

4.24 INVAGEN PHARMS

4.25 IPCA LABS LTD

4.26 LUITPOLD

4.27 MEDICURE

4.28 MYLAN

4.29 NEW RIVER

4.30 PFIZER



5 Blood system drugs Manufacturing Cost Analysis

5.1 Blood system drugs Key Raw Materials Analysis

5.1.1 Key Raw Materials

5.1.2 Price Trend of Key Raw Materials

5.1.3 Key Suppliers of Raw Materials

5.1.4 Market Concentration Rate of Raw Materials

5.2 Proportion of Manufacturing Cost Structure

5.2.1 Raw Materials

5.2.2 Labor Cost

5.2.3 Manufacturing Expenses

5.3 Manufacturing Process Analysis of Blood system drugs



6 Industrial Chain, Sourcing Strategy and Downstream Buyers

6.1 Blood system drugs Industrial Chain Analysis

6.2 Upstream Raw Materials Sourcing

6.3 Raw Materials Sources of Blood system drugs Major Players/Manufacturers in 2016

6.4 Downstream Buyers



7 Marketing Strategy Analysis, Distributors/Traders

7.1 Marketing Channel

7.1.1 Direct Marketing

7.1.2 Indirect Marketing

7.1.3 Marketing Channel Development Trend

7.2 Market Positioning

7.2.1 Pricing Strategy

7.2.2 Brand Strategy

7.2.3 Target Client

7.3 Distributors/Traders List



8 Market Effect Factors Analysis

8.1 Technology Progress/Risk

8.1.1 Substitutes Threat

8.1.2 Technology Progress in Related Industry

8.2 Consumer Needs/Customer Preference Change

8.3 Economic/Political Environmental Change



9 Global and Japan Blood system drugs Market Size (Sales and Revenue) Forecast (2017-2022)

9.1 Global and Japan Blood system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)

9.2 Global and Japan Blood system drugs Sales () Forecast by Type (2017-2022)

9.2.1 by Antianemic Agents

9.2.2 by Antiplatelet drug

9.2.3 by Coagulant Drugs

9.2.4 by Anticoagulant and thrombolytic

9.2.5 by blood volume expander

9.3 Global and Japan Blood system drugs Sales () Forecast by Application (2017-2022)

9.4 Global and Japan Blood system drugs Sales () Forecast by Regions (2017-2022)



10 Research Findings and Conclusion



11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Disclaimer

11.4 Author List





List of Table

List of Tables and Figures



Figure Product Picture of Blood system drugs

Table Japan Blood system drugs Sales (Million Units) Comparison by Applications (2012-2017)

Figure Japan Sales Market Share (%) of Blood system drugs by Applications in 2016

Table Global Blood system drugs Sales (Million Units) Comparison by Applications (2012-2017)

Figure Global Sales Market Share (%) of Blood system drugs by Applications in 2016

Figure department of hematology Examples

Table Key Downstream Customer in department of hematology

Figure Internal Medicine Examples

Table Key Downstream Customer in Internal Medicine

Figure department of surgery Examples

Table Key Downstream Customer in department of surgery

Figure Pharmacy Examples

Table Key Downstream Customer in Pharmacy

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Ferrous sulfate Product Picture

Figure Ferrous succinate Product Picture

Figure RHUEPO Product Picture

Figure Iron-dextrin Product Picture

Figure Vitamin B12 Product Picture

Figure Aspirin Product Picture

Figure Dipyridamole Product Picture

Figure Clopidogrel Product Picture

Figure Prasugrel Product Picture

Figure Ticagrelor Product Picture

Figure Thrombin Product Picture

Figure Etamsylate Product Picture

Figure Menadione Sodium Bisulfite Product Picture

Figure Vitamin K1 Product Picture

Figure Aminomethylbenzoic Acid Product Picture

Figure heparin Product Picture

Figure urokinase Product Picture

Figure Warfarin Product Picture

Figure Bishydroxycoumarin Product Picture

Figure Streptokinase Product Picture

Figure Dextran Product Picture

Figure Polyglucose Product Picture

Table ACTAVIS ELIZABETH Basic Information List

Table ACTAVIS ELIZABETH Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table ACTAVIS ELIZABETH Blood system drugs Sales Growth Rate (%)(2012-2017)

Table ACTAVIS ELIZABETH Blood system drugs Sales Market Share (%) in Japan (2012-2017)

Figure ACTAVIS ELIZABETH Blood system drugs Revenue Market Share (%) in Japan (2012-2017)

Table AKORN Basic Information List

Table AKORN Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table AKORN Blood system drugs Sales Growth Rate (%)(2012-2017)

Table AKORN Blood system drugs Sales Market Share (%) in Japan (2012-2017)

Figure AKORN Blood system drugs Revenue Market Share (%) in Japan (2012-2017)

Table ALLERGAN SALES LLC Basic Information List

Table ALLERGAN SALES LLC Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table ALLERGAN SALES LLC Blood system drugs Sales Growth Rate (%)(2012-2017)

Table ALLERGAN SALES LLC Blood system drugs Sales Market Share (%) in Japan (2012-2017)

Figure ALLERGAN SALES LLC Blood system drugs Revenue Market Share (%) in Japan (2012-2017)

Table AMNEAL PHARMS Basic Information List

Table AMNEAL PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table AMNEAL PHARMS Blood system drugs Sales Growth Rate (%)(2012-2017)

Table AMNEAL PHARMS Blood system drugs Sales Market Share (%) in Japan (2012-2017)

Figure AMNEAL PHARMS Blood system drugs Revenue Market Share (%) in Japan (2012-2017)

Table APOTEX Basic Information List

Table APOTEX Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table APOTEX Blood system drugs Sales Growth Rate (%)(2012-2017)

Table APOTEX Blood system drugs Sales Market Share (%) in Japan (2012-2017)

Figure APOTEX Blood system drugs Revenue Market Share (%) in Japan (2012-2017)

Table ARALEZ PHARMS Basic Information List

Table ARALEZ PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table ARALEZ PHARMS Blood system drugs Sales Growth Rate (%)(2012-2017)

Table ARALEZ PHARMS Blood system drugs Sales Market Share (%) in Japan (2012-2017)

Figure ARALEZ PHARMS Blood system drugs Revenue Market Share (%) in Japan (2012-2017)

Table ASTRAZENECA PHARMS Basic Information List

Table ASTRAZENECA PHARMS Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table ASTRAZENECA PHARMS Blood system drugs Sales Growth Rate (%)(2012-2017)

Table ASTRAZENECA PHARMS Blood system drugs Sales Market Share (%) in Japan (2012-2017)

Figure ASTRAZENECA PHARMS Blood system drugs Revenue Market Share (%) in Japan (2012-2017)

Table AVEDRO INC Basic Information List

Table AVEDRO INC Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table AVEDRO INC Blood system drugs Sales Growth Rate (%)(2012-2017)

Table AVEDRO INC Blood system drugs Sales Market Share (%) in Japan (2012-2017)

Figure AVEDRO INC Blood system drugs Revenue Market Share (%) in Japan (2012-2017)

Table BARR Basic Information List

Table BARR Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table BARR Blood system drugs Sales Growth Rate (%)(2012-2017)

Table BARR Blood system drugs Sales Market Share (%) in Japan (2012-2017)

Figure BARR Blood system drugs Revenue Market Share (%) in Japan (2012-2017)

Table BAXTER HLTHCARE Basic Information List

Table BAXTER HLTHCARE Blood system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table BAXTER HLTHCARE Blood system drugs Sales Growth Rate (%)(2012-2017)

Table BAXTER HLTHCARE Blood system drugs Sales Market Share (%) in Japan (2012-2017)

Figure BAXTER HLTHCARE Blood system drugs Revenue Market Share (%) in Japan (2012-2017)

Table BIOKEY Basic Information List

Table BRECKENRIDGE PHARM Basic Information List

Table BRISTOL MYERS SQUIBB Basic Information List

Table CHIESI USA INC Basic Information List

Table CLOVER PHARMS Basic Information List

Table EMCURE PHARMS LTD Basic Information List

Table FERRING PHARMS INC Basic Information List

Table FRESENIUS KABI USA Basic Information List

Table GENENTECH Basic Information List

Table GLAND PHARMA LTD Basic Information List

Table GLENMARK PHARMS LTD Basic Information List

Table HERITAGE PHARMA Basic Information List

Table HOSPIRA Basic Information List

Table INVAGEN PHARMS Basic Information List

Table IPCA LABS LTD Basic Information List

Table LUITPOLD Basic Information List

Table MEDICURE Basic Information List

Table MYLAN Basic Information List

Table NEW RIVER Basic Information List

Table PFIZER Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Blood system drugs

Figure Manufacturing Process Analysis of Blood system drugs

Figure Blood system drugs Industrial Chain Analysis

Table Raw Materials Sources of Blood system drugs Major Players/Manufacturers in 2016

Table Major Buyers of Blood system drugs

Table Distributors/Traders List

Figure Japan Blood system drugs Sales () and Growth Rate (%) Forecast (2017-2022)

Figure Japan Blood system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Japan Blood system drugs Price () Trend Forecast (2017-2022)

Figure Global Blood system drugs Sales () and Growth Rate (%) Forecast (2017-2022)

Figure Global Blood system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Blood system drugs Price () Trend Forecast (2017-2022)

Table Japan Blood system drugs Sales () Forecast by Type (2017-2022)

Table Global Blood system drugs Sales () Forecast by Type (2017-2022)

Figure Japan Blood system drugs Sales () Forecast by Type (2017-2022)

Figure Global Blood system drugs Sales () Forecast by Type (2017-2022)

Figure Japan Blood system drugs Sales Volume Market Share Forecast by Type in 2017

Figure Global Blood system drugs Sales Volume Market Share Forecast by Type in 2017

Table Japan Blood system drugs Sales () Forecast by Application (2017-2022)

Figure Japan Blood system drugs Sales Volume Market Share Forecast by Application (2017-2022)

Figure Japan Blood system drugs Sales Volume Market Share Forecast by Application in 2017

Table Global Blood system drugs Sales () Forecast by Application (2017-2022)

Figure Global Blood system drugs Sales Volume Market Share Forecast by Application (2017-2022)

Figure Global Blood system drugs Sales Volume Market Share Forecast by Application in 2017

Table Japan Blood system drugs Sales () Forecast by Regions (2017-2022)

Table Japan Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure Japan Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)

Table Global Blood system drugs Sales () Forecast by Regions (2017-2022)

Table Global Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure Global Blood system drugs Sales Volume Share Forecast by Regions (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources



Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *